Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go-Related Gene Potassium Channel
Sean Ekins, William Crumb, R. Dustan Sarazan et al. · Journal of Pharmacology and Experimental Therapeutics · 2002
Cited by 260 works. doi:10.1124/jpet.301.2.427
Authors
References
- A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
- A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel
- The inward rectification mechanism of the HERG cardiac potassium channel
- A structural basis for drug-induced long QT syndrome
- A common polymorphism associated with antibiotic-induced cardiac arrhythmia
- QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience
- A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG
- Blockage of the HERG human cardiac K+channel by the gastrointestinal prokinetic agent cisapride
- Interactions of a Series of Fluoroquinolone Antibacterial Drugs with the Human Cardiac K+ Channel HERG
- Mechanism of Block and Identification of the Verapamil Binding Domain to HERG Potassium Channels